Accordingly, the proportion of subjects with an Adpn/Lep ratio below the lower cut-off point proposed (and considered as of high cardiometabolic risk) is significantly higher in individuals with obesity, T2D or the MS. Here, ADIPOQ is linked to obesity disorder.